click below
click below
Normal Size Small Size show me how
Final Review KINS447
Final Exam Review KINS 447
| Question | Answer |
|---|---|
| The onset of action for a transdermal drug on a runner in hot weather will be | faster |
| Increased metabolism of a drug does what to the blood concentration | decreases |
| the intensity of the drug effect is impacted mainly by | plasma drug concentration |
| major pathway of drug excretion | kidney |
| nonproprietary drug name | generic |
| proprietary drug name | brand/trade |
| passage of the drug from the GI tract to the bloodstream | absorption |
| drug distributed to various tissues in the bloodstream | distribution |
| chemical modification of a drug into metabolites | metabolism |
| injection of a drug into the muscle | intramuscular |
| main parenteral routes of administration include | IV, IM, subq |
| type of administration involving topical patches or ointments | transdermal |
| two main factors determining drug distribution | plasma protein binding and blood flow |
| Study of the action of drugs on living tissue | pharmacodynamics |
| Study of the processes of drug absorption, distribution, metabolism, and excretion. | pharmacokinetics |
| Drug that binds to it's receptor and produces a drug action. | agonist |
| Exact amount of a drug that is administered in order to produce a specific effect. | dose |
| Situations or conditions when a certain drug should not be administered | contraindications |
| study of drugs | pharmacology |
| name that defines the chemical composition of a drug | chemical name |
| the amount of drug administered that is absorbed and reaches the systemic circulation | bioavailability |
| what change occurs to left ventricular mass and thickness with chronic resistance and endurance training | increase |
| what change occurs to stroke volume, resting HR, BP and plasma volume with chronic resistance training | unchanged |
| what change occurs to anaerobic enzymes with chronic resistance training | increased |
| stroke volume increases with exercise intensity, but due to chamber size there is a | plateau |
| the trained individual's heart rate compared to an untrained individual at rest and sub maximal exercise | lower |
| the trained individual's cardiac output compared to an untrained individual is | the same |
| when stroke volume rises in a trained individual, what compensation occurs | HR decreases |
| chronic aerobic training adaptations include increases in | SV, LV volume, capillary density, plasma volume and aerobic enzymes |
| Angiotensin II stimulates the adrenal cortex to release | aldosterone |
| aldosterone stimulates the tubular reabsorption of | sodium and water |
| angiotensin II does what to the arterioles | vasoconstricts |
| angiotensin II does what to total peripheral resistance | increases |
| when total peripheral resistance increases, BP | increases |
| preload, after load, HR and contractility all stimulate | cardiac output |
| the volume of blood remaining in each ventricle following contraction. | end systolic volume |
| the volume of blood ejected by the ventricles with each beat. | stroke volume |
| the maximum amount of blood ejected by the heart each minute | maximum cardiac ouput |
| the pressure in the arteries during the contraction phase of the heart | systolic |
| positive ionotropic effect | greater contractility |
| positive chronotropic effect | faster heart rate |
| main cholinergic receptor, found in smooth muscle and cardiac muscle | muscarinic |
| main neurotransmitter of the sympathetic nervous system | epinephrine |
| main neurotransmitter of the parasympathetic nervous system | acetylcholine |
| nervous system that controls homeostasis in the body | autonomic |
| Dietary Approach to Stop Hypertension | DASH diet |
| balanced diet that is low in fat, saturated fat, cholesterol, and sweets, and high in whole grains, fruits, vegetables, and low-fat dairy products | DASH diet |
| diet more effective a lowering BP than reducing sodium | DASH diet |
| two main lipoproteins | LDL and HDL |
| carrier molecules which are composed of both lipids and proteins | lipoproteins |
| lipoproteins have a phospholipid bilayer to allow them to carry what int he bloodstream | cholesterol and TGs |
| omega-3 fatty acids produce what which limits inflammation in the pathogenesis of atherosclerosis | anti-inflammatory eicosanoids |
| role of antioxidants in the prevention of ASO | protect LDL from being oxidized |
| increased intake of refined carbohydrates (breads, crackers, cereals) will increase what | small, dense LDL |
| LDL is not measured it is estimated because | it's expensive |
| type of LDL that is more atherogenic | small, dense |
| major determinant of the risk of plaque rupture which can result in myocardial infarction. | stability of the plaque |
| abnormally low level of potassium ions in circulating blood. | hypokalemia |
| drugs that inhibit the reabsorption of water | diuretics |
| drugs that inhibit angiotensin formation | ACE inhibitor |
| hypertension with no known cause | essential HTN |
| abnormally high BP | HTN |
| mineral corticoid that causes retention of sodium | aldosterone |
| most important side effect of statins for runners | myopathy |
| calcium channel blockers (CCBs) do what to blood vessels | vasodilate |
| CCBs inhibit the influx of what in arterial smooth muscle | calcium |
| during exercise heat is dissipated through | peripheral vasodilation |
| CCBs do what to total peripheral resistance | decrease |
| main conditions CCBs are used to treat | HTN and angina |
| most commonly used nitrate | nitroglycerin |
| action of nitrates on peripheral smooth vascular muscle | dilate |
| nitrates action the heart workload | decrease |
| nitrates used to treat | MI |
| side effect of nitrates | dizziness and fainting |
| used to lower total cholesterol, LDL and increase HDL | hypolipidemic drugs |
| beta-blockers do what to resting and exercise heart rate | decrease |
| drug class that impairs thermoregulation making it difficult to dissipate heat when exercising | diuretics |
| thiazide diuretics act on what to inhibit the reabsorption of sodium and water | distal convoluted tubule |
| two major concerns with prescribing theophylline for COPD | side effects and drug-drug interactions |
| Lack of moisture in the air may trigger what, potentially causing long term damage to the bronchioles | EIB |
| what stages of COPD will have difficulty exercising for even short periods | II-IV |
| what stage of COPD can begin an exercise program as recommended by the ACSM for healthy individuals | I |
| individuals with EIB should take 2 puffs of their bronchodilator when | 15 min prior to exercise |
| is asthma considered a chronic obstructive pulmonary disease | no, this is controversial |
| two main pathologic features of asthma | bronchoconstriction and inflammation |
| when bronchioles inflame with asthma, what occurs | bronchiole wall thickening and mucus formation |
| allergens such as dust and pollen do what to the bronchioles in those with asthma | inflame and constrict |
| the most effective drug for the long term control of asthma in elite athletes is | corticosteroids |
| the onset of action of a long acting beta 2 agonist | slow |
| long acting beta 2 agonist are used to for | chronic asthma |
| type of drug used most commonly to treat acute asthma attacks | short acting beta-2 agonist |
| high doses of beta-2 agonists may stimulate what in the heart | B1 receptors |
| stimulation of beta-2 receptors in the lungs results in what | bronchodilation |
| activates beta-2 adrenergic receptors on bronchial smooth muscle resulting in bronchodilation | beta-2 agonists |
| inhibits cholinergic receptors on bronchial smooth muscle resulting in bronchodilation | anticholinergics |
| stimulates synthesis of cytokines, inhibits production of LT & PG and inhibits leukocyte infiltration | corticosteroids |
| inhibit lipooxygenase resulting in decreased production of inflammatory mediators | leukotriene modifiers |
| airway hyperresponsiveness occurs in response to exercise | EIB |
| produces allergy symptoms and a local immune response when released | histamine |
| clinically defined as a chronic productive cough | chronic bronchitis |
| causes destruction of the alveolar sacs making it difficult for to expel air | emphysema |
| enzyme induced in response to inflammation | COX-2 |
| have NSAIDs been proven to inhibit DOMS? | no |
| increased risk of what in long distance runners using NSAIDS | GI bleeding and renal failure |
| reason NSAIDs increase risk of renal failure in endurance athletes | inhibit PGs, decrease renal blood flow |
| arginine rich foods, omega-3 FAs, soy protein and physical activity are | anti-inflammatory |
| Bradykinin, prostaglandins, histamine and leukotrienes all increase | vascular permeability |
| chemical mediator involved in the pain response | bradykinin |
| Local anesthetics act by doing what to nerve transmission | inhibit locally |
| factor that attracts specific cell types to the area of injury. | chemotactic factor |
| factors that are released from one type of cell and bind to another cell, coordinating and propagating the inflammatory response. | chemical mediator |
| cells which engulf dead cells and debris from an injury site | neutrophils |
| metabolites of arachidonic acid that increase vascular permeability and induce pain | prostaglandin |
| inhibits substance P | capsicum |
| inhibition of COX in the brain | acetaminophen |
| bind to opioid receptors in the CNS | opioid analgesics |
| binds irreversibly with COX-1 | aspirin |
| Agitation, irritability, dizziness, headache, hand tremor and fatigue in an exercising diabetic | hypoglycemia |
| when blood glucose drops the pancreas releases | glucagon |
| glucagon stimulates the breakdown of | glycogen to glucose |
| excess fructose consumption does what to liver insulin sensitivity | increases resistance |
| excess fructose consumption does what to satiety | diminishes |
| excess fructose consumption does what to uric acid | increases formation |
| excess fructose consumption what to fat storage and synthesis | increases |
| excess fructose consumption does what to glycogen synthesis | increases |
| diabetics should avoid exercise at night due to risk of | post-exercise hypoglycemia |
| diabetics should assess intensity with RPE and not HR due to | blunted response to HR |
| despite possible blunted response to BP in a diabetic, BP should be monitored due to risk of | hyper or hypotension |
| what nutrient should be adjusted in a DM when starting a new exercise program | carb intake |
| caused by glycoproteins in the blood vessel wall, basement membrane weakening, diminished blood flow to organs | "micro"angiopathy |
| drug increases the release of insulin from the pancreas | glipizide (sulfonylurea) |
| inhibits gluconeogenesis in the liver | metformin (biguanide) |
| insulin sensitizer in fat and muscle | Avandia (glitazone) |
| decreases the absorption of glucose from the small intestines | Prelose (alpha-glucosidase inhibitor) |
| preserve the insulin producing capacity of B-cells in the pancreas while stimulating the release of insulin | Byetta (Incretin mimetic) |
| inhibit the enzyme responsible for inactivating incretin hormones | Januvia (DPP-4 Inhibitors) |
| contraindication for resistance training in diabetics | retinopathy |
| secreted by pancreatic beta cells to slow the rate of glucose absorption | amylin |
| peptide hormone that enhances insulin release by the pancreas | incretin |
| the underlying defect in type 2 diabetes | insulin resistance |
| can cause a blunted response to hypoglycemia and changes in blood | autonomic neuropathy |
| damage to the kidneys, commonly caused by diabetes | nephropathy |
| If there is evidence that a dietary supplement is unsafe, the FDA must | take appropriate enforcement action |
| Manufacturers are not required to prove what prior to their product going to market | safety or effectiveness |
| a supplement label can make claims regarding disease prevention, ergogenic benefit and aging, but not | treatment of a disease |
| The only intended route of administration for dietary supplements is by | ingestion |
| structure-function claims cannot make the claim to | treat or proven diseases |
| an amino sugar which makes up GAGs which are part of proteoglycans in articular cartilage | glucosamine |
| one of the largest studies with glucosamine shows there is little benefit compared to placebo in treatment of | osteoarthritis |
| glucosamine should be avoided in those with an allergy to | shellfish |
| glucosamine should be used with caution in diabetics due to | raising insulin levels |
| glucosamine and chondroitin work by incorporating into | articular cartilage |
| abbreviation for Dietary Supplement Health and Education Act | DSHEA |
| DSHEA categorized herbs as dietary supplements and dietary supplements as a subcategory of | foods (not drugs) |
| independent labs found what about the ingredients in common dietary supplements | not accurately represented on a label |
| herb proposed to treat depression | St John's Wort |
| herb proposed to improve memory and concentration | ginkgo biloba |
| herb proposed to treat benign prostatic hypertrophy | saw palmetto |
| herb proposed to relieve stress | kava |
| herb proposed to enhance healing | echinacea |
| herb proposed to treat menstrual cramps | black cohosh |
| herb proposed to prevent migraines | feverfew |
| herb proposed to reduce BP and improve blood lipids | garlic |
| alcohol does what to gluconeogenesis (formation of glucose) | inhibits |
| alcohol does what to fluid loss | increases |
| alcohol does what to protein synthesis | inhibits |
| alcohol does what to B-vitamin absorption | inhibits |
| caffeine does what to muscle lipid oxidation | increases |
| caffeine has what effect on glycogen | glycogen sparing |
| caffeine has what effect on skeletal muscle contraction | enhances |
| caffeine does what to mental alertness | increases |
| caffeine does what to the perception of fatigue | decreases |
| caffeine does what to protein synthesis | no effect |
| cocaine does what to the perception of fatigue | decreases |
| cocaine does what to heat loss during exercise | diminishes |
| cocaine does what to temperature regulation | impairs |
| cocaine does what to heat production during exercise | increases |
| cocaine has what impact on protein synthesis | no impact |
| dilated pupils, dry mouth, lip licking, restlessness, reduced appetite, weight loss and irritability are signs of | amphetamine use |
| caffeine binds to what receptor in the brain | adenosine |
| caffeine inhibits the depression of what in the brain | nerve cell activity |
| alcohol inhibits the release of what hormone which results in increased urine production | alcohol dehydrogenase (ADH) |
| acute cannabinoid use has what impact on heart rate | increase 20-50 beats/min |
| solubility of cannabinoids | fat soluble |
| A JAMA study on low cumulative marijuana use showed what impact on pulmonary function | no impairment |
| amphetamines use during physical activity in warm weather can result in fatalities due to | heat stroke |
| drug class including amphetamines, ephedrine and caffeine | stimulants |
| drug effects include increased blood pressure, heart rate, respiratory rate and release of dopamine | amphetamines |
| drug banned by the NCAA when urine levels exceed 15 ug/mL | caffeine |
| neurotransmitter that depresses nerve cell activity, causing drowsiness | adenosine |
| drug metabolized to benzoylecgonine | cocaine |
| abbreviation for delta-9-tetrahydrocannabinol | THC |
| increased muscle mass, strength, fat free mass, accelerated bone growth are what type of effects associated with AAS | anabolic effects |
| regulate muscle & bone growth and regulate metabolic processes is the primary function of what | human growth hormone |
| physiological, pharmacological, mechanical and nutritional are all considered what | ergogenic aids |
| aggression, hostility and anger are side effects of what | AAS |
| reduced sperm production and testicular size in men are side effects of what | AAS |
| development of masculine features in women is a side effect of what | AAS |
| oily skin, hair and acne is a side effect of what | AAS |
| AAS stimulate the growth of | protein (muscle and bone) |
| glucocorticoids and mineralocorticoids are in a class of steroids called | corticosteroids |
| steroids which decrease inflammation and increase the breakdown of muscle | glucocorticoids |
| steroids which decrease the use of glucose and increase insulin resistance | glucocorticoids |
| steroids involved in regulating fluid balance | mineralocorticoids |
| glycoprotein hormone used in athletes to increase red blood cells | EPO |
| use of r-EPO does what to endogenous EPO production | suppresses |
| use of EPO does what to blood viscosity | increases |
| athletes who use EPO are at risk for what conditions | MI/stroke |
| which PED promotes glucose and amino acid transport into muscle cells | hGH |
| which PED promotes the utilization of amino acids for protein synthesis | hGH |
| hGH is administered by which route | injection |
| an athlete must consume adequate protein and train at a high intensity to obtain benefits of | AAS |
| at what amount greater than the therapeutic dose do athletes common use AAS | 10-100X greater |
| immediate precursor to androstenedione and available over the counter | DHEA |
| precursor to testosterone | androstenedione |
| which drug class is banned during competition in precision sports because they reduce anxiety and tremor | beta-blockers |
| athletes use this drug class to mask the effect of other PEDs | diuretics |
| external influence which can positively affect sporting performance | ergogenic aid |
| PED proposed, but not proven, to increases lean body mass, improve muscle strength and athletic performance. | hGH |
| hGH stimulates the growth of | all tissues |
| one of the more serious side effects of AAS use | liver abnormalities |
| AAS are used by what type of athletes | amateur and pro |
| what type of injections deliver growth factors to an injured area to speed healing, but not banned by WADA | PRP |
| supplement that increases protein synthesis and spares glucose | beta-alanine |
| acts as a stimulant, suppresses appetite and can be found in "ephedra free" supplements | citrus aurantium |
| popular supplement very effective at promoting muscular hypertrophy | creatine |
| supplement that decreases dehydration, but has not been shown to improve body composition | L-alanyl-L-glutamine |
| supplement that increases body weight & whole lean body mass and decreases DOMS symptoms | alfa-hydroxy-isocaproic acid (HICA) |
| increase muscle mass and strength in untrained athletes, but no benefit shown in trained athletes. | B-hydroxy B-methylbuturate (HMB) |
| an athlete tested positive for a drug that he was actually not taking | false positive |
| stimulants, oxygen enhancers and relaxants are likely to be used when | during competition |
| depressants are most likely to be used | recreationally |
| anabolic steroids and growth hormone are more likely to be used | during training |
| coordinates anti-doping enforcement for international competitions and the Olympics | WADA |
| international, nonprofit, umbrella organization that supervises the summer and winter Olympics | IOC |
| implement doping control in the Olympic Games | WADA and local committees |
| operates under the umbrella of the IOC and administer anti-doping programs | IAF |
| student athletes have unsuccessfully claimed what in drug testing cases against organizations | 14th amendment rights |
| the NCAA can institute a drug testing policy without violating an athlete's constitutional rights because | not considered state actor |
| public colleges and universities are considered state actors and therefore subject to | constitutional challenges |
| goal of a successful anti-doping program is to influence human behavior, not to | prosecute athletes |
| what includes the administration of blood, red blood cells or artificial oxygen carriers | blood doping |
| recombinant human EPO which was initially introduced for the treatment of disease | rHuEPO |
| what tests measures rHuEPO | no direct test |
| substances can be masked in the urine by taking diuretics or | over-hydrating |
| changing the pH of the urine by consuming | acidic fruit juices or aspirin |
| antiquated methodology to interfere with the TLC test for opiates | consuming golden seal |
| blood doping was recognized as a performance enhancing agent in | the 1980s |
| doping is derived from which Dutch word, which means opium juice | ¨doop¨ |
| the use of ergogenic aids in sports dates back to | 400 BC |
| the ancient Greeks used what to fight fatigue | stimulants |
| the IOC began testing in | 1964 |
| the IOC had a defined list of prohibited drugs in | 1968 |
| an error in the Custody and Control Form is a | fatal flaw |
| The inability to urinate in public restrooms is called | shy bladder |
| Chain of custody refers to the documentation required when handing a specimen from the time of collection until | results are reported |
| surveys indicate that most college and high school athletes support or do not support drug testing? | support |
| not every student at a public school can be drug tested because of | constitutional constraints |
| use of genes to modulate genetic expression of particular proteins to improve athletic performance | gene doping |
| hGH (human growth hormone) detection is difficult because metabolism of the peptide is | fast |
| The most commonly used specimen for drug testing is | urine |
| drug testing specimen with easy analysis due to limited amount of protein and cellular constituents | urine |
| drug testing specimen with strong correlation between concentration of the drug and effect on performance | blood |
| drug testing specimen that is non-invasive and easy to perform, but citrus can skew results | saliva |
| drug testing specimen with a large detection window, beneficial in identifying false-negative results | hair |